← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Teladoc Health, Inc.: Revenue declined 1.5% to $2.53B from $2.57B. Net loss narrowed to $200M from $1.001B. Free cash flow grew 0.9% to $285M from $283M. Operating margin expanded 2934 bps to -10.39%. Teladoc Health, Inc.'s annual comparison also shows inventory grew faster than revenue; the balance-sheet screen falls in the distress range and requires business-model context.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 1.5% to $2.53B from $2.57BWatch
- Profitability — Net loss narrowed to $200M from $1.001BOK
- Cash flow — Free cash flow grew 0.9% to $285M from $283MOK
- Margins — Operating margin expanded 2934 bps to -10.39%OK
- Accounting — Distress-range screen needs contextWatch
- Insiders — 1 purchase and 32 salesOK
Business
Comprehensive Suite of Virtual Care Clinical Services We believe that we are the first and only company to offer a comprehensive and integrated virtual care solution that both provides and enables care for a full spectrum of clinical conditions, including wellness and prevention, acute care, chronic conditions, and complex healthcare needs.
Where the revenue comes from
Fiscal 2025, as Teladoc Health, Inc. reports it. History and quarterly detail are in the app.
- Integrated Care$1.6B
- BetterHelp$950.4M
Leadership changes
From Teladoc Health, Inc.'s own filings, the day they're filed.
- Thomas G. McKinley · directors · departureeff. 2026-02-20
- Michael Waters · Chief Operating Officer · departureeff. 2024-09-27
- Laizer Kornwasser · President · departureeff. 2024-07-01
Latest filings
- 8-K · Company announcement2026-08-31
- 8-K · Company announcement2026-08-13
- 8-K · Company announcement2026-08-03
- 10-Q · Quarterly report2026-07-30
- 8-K · Company announcement2026-07-29
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Teladoc Health, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.